Literature DB >> 3880727

Shiga-like cytotoxin production by enteropathogenic Escherichia coli serogroups.

T G Cleary, J J Mathewson, E Faris, L K Pickering.   

Abstract

The mechanism by which enteropathogenic Escherichia coli (EPEC) cause disease remains to be defined. We studied EPEC and non-EPEC strains of E. coli from stool specimens obtained from infants and adults for production of Shiga-like cytotoxin. Although it was common for healthy infants and adults to have cytotoxin-producing E. coli as part of the fecal flora, Shiga-like cytotoxin was detected more commonly and in greater amounts among EPEC than among other fecal E. coli. These results suggest a role for Shiga-like cytotoxin in the pathogenesis of EPEC-related gastroenteritis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3880727      PMCID: PMC261520          DOI: 10.1128/iai.47.1.335-337.1985

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  10 in total

1.  Properties of an Escherichia coli cytotoxin.

Authors:  J Konowalchuk; N Dickie; S Stavric; J I Speirs
Journal:  Infect Immun       Date:  1978-05       Impact factor: 3.441

2.  Enteropathogenic Escherichia coli: lack of correlation of serotype with pathogenicity.

Authors:  M C Goldschmidt; H L DuPont
Journal:  J Infect Dis       Date:  1976-02       Impact factor: 5.226

3.  From the National Institute of Allergy and Infectious Diseases. Summary of a workshop on enteropathogenic Escherichia coli.

Authors:  R Edelman; M M Levine
Journal:  J Infect Dis       Date:  1983-06       Impact factor: 5.226

4.  The clonal nature of enteropathogenic Escherichia coli strains.

Authors:  J Stenderup; F Orskov
Journal:  J Infect Dis       Date:  1983-12       Impact factor: 5.226

5.  Vero response to a cytotoxin of Escherichia coli.

Authors:  J Konowalchuk; J I Speirs; S Stavric
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

6.  Characterization of Shigella dysenteriae 1 (Shiga) toxin purified by anti-Shiga toxin affinity chromatography.

Authors:  A D O'Brien; G D LaVeck; D E Griffin; M R Thompson
Journal:  Infect Immun       Date:  1980-10       Impact factor: 3.441

7.  Escherichia coli O157:H7 strains associated with haemorrhagic colitis in the United States produce a Shigella dysenteriae 1 (SHIGA) like cytotoxin.

Authors:  A O O'Brien; T A Lively; M E Chen; S W Rothman; S B Formal
Journal:  Lancet       Date:  1983-03-26       Impact factor: 79.321

8.  Purification and characterization of a Shigella dysenteriae 1-like toxin produced by Escherichia coli.

Authors:  A D O'Brien; G D LaVeck
Journal:  Infect Immun       Date:  1983-05       Impact factor: 3.441

9.  Production of Shigella dysenteriae type 1-like cytotoxin by Escherichia coli.

Authors:  A D O'Brien; G D LaVeck; M R Thompson; S B Formal
Journal:  J Infect Dis       Date:  1982-12       Impact factor: 5.226

10.  Failure to detect conventional enterotoxins in classical enteropathogenic (serotyped) Escherichia coli strains of proven pathogenicity.

Authors:  R M Robins-Browne; M M Levine; B Rowe; E M Gabriel
Journal:  Infect Immun       Date:  1982-11       Impact factor: 3.441

  10 in total
  24 in total

1.  Low frequency of high level Shiga-like toxin production in enteropathogenic Escherichia coli 0 serogroups.

Authors:  N Cimolai; C Trombley
Journal:  Eur J Pediatr       Date:  1992-02       Impact factor: 3.183

2.  Improved biochemical screening procedure for small clinical laboratories for vero (Shiga-like)-toxin-producing strains of Escherichia coli O157:H7.

Authors:  D J Haldane; M A Damm; J D Anderson
Journal:  J Clin Microbiol       Date:  1986-10       Impact factor: 5.948

Review 3.  Enteric bacterial toxins: mechanisms of action and linkage to intestinal secretion.

Authors:  C L Sears; J B Kaper
Journal:  Microbiol Rev       Date:  1996-03

Review 4.  Escherichia coli that cause diarrhea.

Authors:  M M Levine; P Vial
Journal:  Indian J Pediatr       Date:  1988 Mar-Apr       Impact factor: 1.967

5.  Isolation of Shiga toxin-resistant Vero cells and their use for easy identification of the toxin.

Authors:  U Kongmuang; T Honda; T Miwatani
Journal:  Infect Immun       Date:  1988-09       Impact factor: 3.441

6.  Production of Shiga-like toxin among Escherichia coli strains and other bacteria isolated from diarrhea in São Paulo, Brazil.

Authors:  R Giraldi; B E Guth; L R Trabulsi
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

7.  Evidence that glutamic acid 167 is an active-site residue of Shiga-like toxin I.

Authors:  C J Hovde; S B Calderwood; J J Mekalanos; R J Collier
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

Review 8.  Shiga and Shiga-like toxins.

Authors:  A D O'Brien; R K Holmes
Journal:  Microbiol Rev       Date:  1987-06

9.  Rapid method to detect shiga toxin and shiga-like toxin I based on binding to globotriosyl ceramide (Gb3), their natural receptor.

Authors:  S Ashkenazi; T G Cleary
Journal:  J Clin Microbiol       Date:  1989-06       Impact factor: 5.948

10.  Quantitative analysis and partial characterization of cytotoxin production by Salmonella strains.

Authors:  S Ashkenazi; T G Cleary; B E Murray; A Wanger; L K Pickering
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.